Novartis AG (NVS)
146.45
-2.71
(-1.82%)
USD |
NYSE |
Jun 08, 16:00
146.45
0.00 (0.00%)
After-Hours: 18:34
Novartis Market Cap : 279.44B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 563.15B |
| GSK Plc | 101.85B |
| Johnson & Johnson | 558.83B |
| Eli Lilly & Co. | 1.083T |
| Merck & Co., Inc. | 295.13B |
Market Cap Related Metrics
| PE Ratio | 20.87 |
| PS Ratio | 5.188 |
| PEG Ratio | 2.083 |
| Price to Book Value | 7.256 |
| Price to Free Cash Flow | 17.67 |
| Price | 146.45 |
| Earnings Yield | 4.79% |
| PEGY Ratio | 1.582 |
| Operating PE Ratio | 17.48 |
| Normalized PE Ratio | 19.85 |